journal article·2016-06

3D compartmented model to study the neurite-related toxicity of Aβ aggregates included in collagen gels of adaptable porosity

Marie-Noëlle Labour, Sylvain Vigier, Dan Lerner, Anne Marcilhac, Emmanuel Belamie

Acta Biomaterialia· Volume 37
Publisher page

Abstract

Unlabelled Insoluble deposits of β-amyloid (Aβ) are associated to neurodegenerative pathologies, in particular Alzheimer's Disease (AD). The toxicity of synthetic amyloid-like peptides has been largely demonstrated and shown to depend upon their aggregation state. However, standard 2D cell culture conditions are not well suited to study the role of the close vicinity of Aβ aggregates and growing neurites in the degenerative process. Here, we have designed a compartmented set-up where model neural cells are differentiated on the surface of Aβ-containing collagen matrices. The average pore size can be modulated, from below 0.2μm to more than 0.5μm by simple treatment with collagenase, to respectively hamper or permit neurite outgrowth towards the depth of the matrix. Dense Aβ aggregates (Congo red and ThT-positive) were obtained inside the collagen matrix with a homogeneous distribution and dimensions similar to those observed in post-mortem brain slices from Alzheimer's patients. The aggregates are not toxic to cells when the pore size is small, in spite of relatively high concentrations of 0.05-0.62mg of peptide per gram of collagen (equivalent to 11.3-113μM). In contrast, on Aβ-containing matrices with large pores, massive neural death is observed when the cells are seeded in the same conditions. It is the first time to our knowledge that Aβ aggregates with a typical morphology of dense plaques are obtained within a porous biomimetic matrix, and are shown to be toxic only when accessible to differentiating cells. Statement of significance Insoluble deposits of β-amyloid (Aβ) are associated to neurodegenerative pathologies, in particular Alzheimer's Disease (AD). In this study, we have formed Aβ aggregates directly inside a biomimetic collagen matrix loaded with growth factors to induce the differentiation of PC12 or SH-SY6Y cells. For the first time, we show that when the contact between cells and Aβ aggregates is allowed by opening up the matrix porosity, the close vicinity with aggregates induces neurite dystrophy. The compartmented 3D culture model developed and used in this study is a valuable tool to study the cytotoxicity of preformed dense Aβ aggregates and proves that contact between the aggregates and neurons is required to induce neurodegenerative processes.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Supramolecular Self-Assembly in Materials · Pickering emulsions and particle stabilization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (84)

Show source-provided references
1. Mechanisms of disease Alzheimer’s disease10.1056/NEJMra0909142 ↗
2. Toward a comprehensive theory for Alzheimer’s disease – hypothesis: Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein
3. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy10.1523/JNEUROSCI.23-02-00493.2003 ↗
4. Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer’s disease10.1016/S0306-4522(02)00241-5 ↗
5. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons10.1523/JNEUROSCI.1189-06.2006 ↗
6. The toxic A beta oligomer and Alzheimer’s disease: an emperor in need of clothes10.1038/nn.3028 ↗
7. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer’s disease10.1007/s00401-010-0679-9 ↗
8. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration10.1073/pnas.1017033108 ↗
9. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function10.1016/j.neuroscience.2007.10.054 ↗
10. Structural features and cytotoxicity of amyloid oligomers: Implications in Alzheimer’s disease and other diseases with amyloid deposits10.1016/j.pneurobio.2012.03.002 ↗
11. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability10.1074/jbc.M201750200 ↗
12. B-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis10.1006/nbdi.1998.0228 ↗
13. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red10.1073/pnas.91.25.12243 ↗
14. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state10.1523/JNEUROSCI.13-04-01676.1993 ↗
15. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis10.1074/jbc.M210207200 ↗
16. Assembly and aggregation properties of synthetic Alzheimer’s A4/beta amyloid peptide analogs10.1016/S0021-9258(18)48529-8 ↗
17. Development of sympathetic neurons in compartmentalized cultures. II. Local control of neurite survival by nerve growth factor10.1016/0012-1606(82)90233-0 ↗
18. Apoptosis is secondary to non-apoptotic axonal degeneration in neurons exposed to Ab in distal axons10.1016/j.neurobiolaging.2005.06.007 ↗
19. TGF-beta 1 blockade of microglial chemotaxis toward A beta aggregates involves SMAD signaling and down-regulation of CCL510.1186/1742-2094-7-28 ↗
20. Microfluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-beta on microglial accumulation10.1038/srep01823 ↗
21. Beta-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network
22. Beta-Amyloid impairs axonal BDNF retrograde trafficking10.1016/j.neurobiolaging.2009.05.012 ↗
23. Designing materials to direct stem-cell fate10.1038/nature08602 ↗
24. Replication of the 3D architecture of tissues10.1016/S1369-7021(10)70015-8 ↗
25. Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels10.1038/nprot.2012.051 ↗
26. Thick collagen-based 3D matrices including growth factors to induce neurite outgrowth10.1016/j.actbio.2012.05.015 ↗
27. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels10.1016/j.expneurol.2003.10.016 ↗
28. Functional synapse formation among rat cortical neurons grown on three-dimensional collagen gels10.1016/S0304-3940(03)00083-1 ↗
29. Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures10.1016/0168-3659(93)90165-2 ↗
30. Defining the concentration gradient of nerve growth factor for guided neurite outgrowth10.1016/S0306-4522(01)00029-X ↗
31. Immobilized concentration gradients of nerve growth factor guide neurite outgrowth10.1002/jbm.a.10168 ↗
32. The use of immobilized neurotrophins to support neuron survival and guide nerve fiber growth in compartmentalized chambers10.1016/j.biomaterials.2010.05.070 ↗
33. Regenerating Islet-derived 1 alpha (Reg-1 alpha) protein Is new neuronal secreted factor that stimulates neurite outgrowth via exostosin tumor-like 3 (EXTL3) receptor10.1074/jbc.M111.260349 ↗
34. Microwave exposure impairs synaptic plasticity in the rat hippocampus and PC12 cells through over-activation of the NMDA receptor signaling pathway
35. Stimulation of autophagy prevents amyloid-beta peptide-induced neuritic degeneration in PC12 Cells10.3233/JAD-132270 ↗
36. Amyloid beta-abrogated TrkA ubiquitination in PC12 cells analogous to Alzheimer’s disease10.1111/jnc.13076 ↗
37. Fibrillogenesis in dense collagen solutions: a physicochemical study10.1016/j.jmb.2007.12.047 ↗
38. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline10.1021/ac60205a053 ↗
39. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status10.1007/s12154-009-0027-5 ↗
40. Spectral properties of Thioflavin T and its complexes with amyloid fibril10.1023/B:JAPS.0000016303.37573.7e ↗
41. Techniques to study amyloid fibril formation in vitro10.1016/j.ymeth.2004.03.012 ↗
42. Bone matrix like assemblies of collagen: from liquid crystals to gels and biomimetic materials10.1016/j.micron.2005.07.005 ↗
43. The formation of fibrils from collagen solutions. 2. A mechanism of collagen-fibril formation10.1042/bj0750598 ↗
44. Amyloid beta peptide of Alzheimer’s disease downregulates Bcl-2 and upregulates bax expression in human neurons10.1523/JNEUROSCI.16-23-07533.1996 ↗
45. Substrate-bound β-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures10.1046/j.1471-4159.2000.741122.x ↗
46. On binding of congo red by amyloid10.1177/10.3.355 ↗
47. Relation of properties of congo red-stained amyloid fibrils to beta-conformation10.1177/20.10.821 ↗
48. Quantitative-evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation10.1177/37.8.2666510 ↗
49. Molecular mechanism of Thioflavin-T binding to amyloid fibrils10.1016/j.bbapap.2010.04.001 ↗
50. Quantification of beta-sheet amyloid fibril structures with thioflavin T10.1016/S0076-6879(99)09020-5 ↗
51. Spectral properties of thioflavin T in solvents with different dielectric properties and in a fibril-incorporated form10.1021/pr0605567 ↗
52. Transient dynamics of A beta contribute to toxicity in Alzheimer’s disease10.1007/s00018-014-1634-z ↗
53. Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats10.1016/j.ajpath.2011.03.021 ↗
54. Size frequency distributions of abnormal protein deposits in Alzheimer’s disease and variant Creutzfeldt-Jakob disease
55. Preferential outgrowth of central nervous-system neurites on astrocytes and schwann-cells as compared with nonglial cells-invitro10.1083/jcb.100.1.198 ↗
56. Myelination determines the caliber of dorsal-root ganglion neurons in culture10.1523/JNEUROSCI.05-06-01563.1985 ↗
57. A beta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures10.1016/j.bpj.2008.11.056 ↗
58. Cooperative ordering of collagen triple helices in the dense state10.1021/la070093z ↗
59. What determines the size frequency-distribution of beta-amyloid (a-beta) deposits in Alzheimers-disease patients10.1016/0304-3940(95)11325-Q ↗
60. The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease10.1016/S0306-4522(01)00169-5 ↗
61. Effects of confinement on insulin amyloid fibrils formation10.1007/s00249-007-0137-3 ↗
62. Enhanced aggregation of beta-amyloid-containing peptides by extracellular matrix and their degradation by the 68kDa serine protease prepared from human brain10.1016/S0304-3940(96)13235-3 ↗
63. Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis10.1074/jbc.M513827200 ↗
64. Type I collagen prevents amyloid aggregation of hen egg white lysozyme10.1016/j.bbrc.2014.04.135 ↗
65. An analysis of the effects of Alzheimers plaques on living neurons10.1016/0197-4580(93)90002-S ↗
66. Alzheimer a-beta amyloid forms an inhibitory neuronal substrate10.1046/j.1471-4159.1994.62031227.x ↗
67. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies10.1093/brain/awn312 ↗
68. Mechanisms of amyloid plaque pathogenesis10.1007/s00401-007-0284-8 ↗
69. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer’s disease
70. Beta-amyloid plaques: stages in life or independant origin ?10.1159/000017051 ↗
71. Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences10.1002/bip.10561 ↗
72. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3 beta10.1073/pnas.1237107100 ↗
73. Beta amyloid peptide: from different aggregation forms to the activation of different biochemical pathways10.1007/s00249-009-0439-8 ↗
74. Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E10.1074/jbc.M701823200 ↗
75. Aggregation of Alzheimer’s amyloid beta-peptide in biological membranes: a molecular dynamics study10.1021/bi400562x ↗
76. Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-beta peptide are competing processes as a result of distinct patterns of motif interplay10.1074/jbc.M111.281295 ↗
77. Quantitative analysis of axonal transport by using compartmentalized and surface micropatterned culture of neurons10.1021/cn3000026 ↗
78. A critical analysis of the ‘amyloid cascade hypothesis’10.5114/fn.2014.45562 ↗
79. On the origin of Alzheimer’s disease. Trials and tribulations of the amyloid hypothesis10.1016/j.arr.2013.10.001 ↗
80. Advances in microfluidics-based experimental methods for neuroscience research10.1039/c2lc41081h ↗
81. Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers10.1039/c1lc20014c ↗
82. The present and future role of microfluidics in biomedical research10.1038/nature13118 ↗
83. Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices10.1016/j.bios.2014.07.029 ↗
84. Poly(dimethylsiloxane) (PDMS) affects gene expression in PC12 cells differentiating into neuronal-like cells10.1371/journal.pone.0053107 ↗